Pulmonology clinician

Ofstead on-demand webinar

Risks and best practices for bronchoscope use on COVID-19 patients


Listen to this 20-minute on-demand webinar or read the executive summary to learn about:

• New front-line evidence based on bronchoscopies performed on COVID-19 patients

• The risks bronchoscopy reprocessing personnel face due to potential exposure to contaminated bronchoscopes

• Recommendations for how to protect both patients and staff

Watch webinar

Executive summary:

Risks and best practices for bronchoscope use on COVID-19 patients

Ofstead & Associates




“Given the high bronchoscope contamination rates found during routine use in previous studies, we must now consider the possibility of bronchoscopy-associated transmission of COVID-19 or other pathogens that could cause secondary infections.”

Cori Ofstead Et al.1



Cori Ofstead, President and CEO at Ofstead & Associates, Inc.

Cori Ofstead, an epidemiologist with 25 years of research experience, leads a multidisciplinary team that specializes in designing and conducting real-world studies to validate healthcare guidelines, treatments, and product claims.

Discussion of the effectiveness of reprocessing flexible bronchoscopes by The American College of Chest Physicians with Cori Ofstead, MSPH and Atul C. Mehta, MBBS
Go to CHEST Journal Podcasts to listen

Infection control
Is contamination of bronchoscopes really a problem? Get an overview of the risks and financial impact associated with reprocessing of reusable bronchoscopes.
Learn how cross-contamination can affect workflow and costs


[1] Ofstead, C., Hopkins, K., Binnicker, M., & Poland, G. (n.d.). Potential impact of contaminated bronchoscopes on novel coronavirus disease (COVID-19) patients. Infection Control & Hospital Epidemiology, 1-10. doi:10.1017/ice.2020.102